Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Taetle

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Blood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J Mendelsohn
International Journal of Cancer|September 15, 1983
Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cellsR Taetle, J M Honeysett, I Trowbridge
Journal of the National Cancer Institute|August 16, 1989
Combination iron depletion therapyR Taetle, J M Honeysett, R Bergeron
Annals of Internal Medicine|August 1, 1978
Hypercalcemia and tamoxifen readministeredR Taetle, J Mendelsohn, M R Green
Blood|August 1, 1979
Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibodyR Taetle, T A Lane, J Mendelsohn
Cancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R Taetle
Journal of the National Cancer Institute|October 3, 1990
Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicityM J Kelner, T C McMorris, R Taetle
Journal of Cellular Physiology|December 1, 1985
Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cellsK Rhyner, R Taetle, H Bering, et al.
Cancer Research|May 1, 1981
In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenograftsR Taetle, A K Koessler, S B Howel
Experimental Hematology|November 1, 1980
Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disordersR Taetle, J P Guittard, J M Mendelsohn
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Blood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J Mendelsohn
International Journal of Cancer|September 15, 1983
Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cellsR Taetle, J M Honeysett, I Trowbridge
Journal of the National Cancer Institute|August 16, 1989
Combination iron depletion therapyR Taetle, J M Honeysett, R Bergeron
Annals of Internal Medicine|August 1, 1978
Hypercalcemia and tamoxifen readministeredR Taetle, J Mendelsohn, M R Green
Blood|August 1, 1979
Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibodyR Taetle, T A Lane, J Mendelsohn
Cancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R Taetle
Journal of the National Cancer Institute|October 3, 1990
Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicityM J Kelner, T C McMorris, R Taetle
Journal of Cellular Physiology|December 1, 1985
Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cellsK Rhyner, R Taetle, H Bering, et al.
Cancer Research|May 1, 1981
In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenograftsR Taetle, A K Koessler, S B Howel
Experimental Hematology|November 1, 1980
Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disordersR Taetle, J P Guittard, J M Mendelsohn
Pageof 13